Urinary excretion levels of five pteridines in healthy cats and dogs and in 14 groups of animals with tumours or virus infections were determined by HPLC after partial purification by ion exchange chromatography. Healthy cats and dogs produce species specific differences. In contrary to cats 6-hydroxymethylpterin was not detectable in dogs. Whereas in dogs biopterin presents the main part of pteridines (about 70%), cats contain about 53% catabolic isoxanthopterin in the pteridine pattern. In the various tumours no qualitative but quantitative alterations in the pteridine concentrations could be detected . The changes in the different tumours were not applied to all pteridines, so that each type of tumour shows an own pattern of pteridines.
Introduction
There are indications that pteridines, as steps of the purine metabolism, represent a new diagnostic aid for the diagnosis of diseases concerning the immunosystern. It is well known from human medicine that pteridines, especially neopterin, are markers for the activation of the T-lymphocyte-macrophage system. All diseases in which the cellular immune response plays an essential role show changes in urinary pteridine excretion, e. g. viral and autoimmune disease and malignant tumours of the urological and gynaecological tracts and of the haematological system (1,2, 3).
Tetrahydrobiopterin is the coenzyme for different monooxygenases (4) responsible for the hydroxylation of phenylalanine, tyrosine and tryptophan, substantial steps in the biosynthesis of neurotransmitters. Elevated concentrations of these amino acids were
The aim of this work was to clarify by qualitative and quantitiative determinations, which pteridines occur in healthy animals and wether alterations in the pteridine pattern appear in various neoplasias and viral infections.
Material and Methods

Patients and controls
Urine samples from sick dogs and controls were collected by catheter in the morning and were either examined immediately or stored at -20°C. Samples of urine were obtained from various groups as follows :
dogs: cats:
28 dogs of various size and breed, of both sexes and free from disease, served as . controls, 21 dogs with malignant mammary tumours. 14 dogs with tumours of the perianal glands. 9 dogs with testicular tumours. 8 The urinary pteridine levels were correlated to creatinine concentration, so as to eliminate the physiological variations of urinary concentration. Analysis of pteridines were performed without knowledge of the clinical diagnosis. All animals were from the Surgical Clinic and from the Medical Clinic of the Veterinary Faculty of Munich. Diagnosis of the tumours were performed by the Pathological Institute.
Instrumentation
The high pressure liquid chromatograph consisted of a Biotronik BT 3020 pump, an automatic sample injector Deripas BT 0421 (Biotronik, Maintal, FRG) and a fluorescence detector Model RF-530 (Shimadzu, Japan). Pteridines were monitored with excitation at 350 nm and emission at 450 nm.
Separation was made with a ready-to-use column (500 x 4.6 mm ID) packed with 5 Il-Spherisorb ODS II. The quantification of the chromatogram was achieved with a chromatopac C-R3A (Shimadzu, Japan) using the external standard method.
Sample preparation
Pteridines in urine are present in their reduced and oxidized forms. Acidic oxidation converts all forms of pteridines to the fully oxidized forms and is thus a measure of the total amount present (7). Urine (1 ml) was acidified by adding 300 III of 1 molll HCl and oxidized with 200 III of 0.5% I I I % KI in 0.1 moll l HCI. After incubation in the dark (1 h), 200 III of 1 % ascorbic acid were added to reduce the excess iodine and centrifuged. The oxidized pteridines in the supernatant were purified by Dowex H + chromatography (Dowex 50 WX8, 100 -200 mesh) as described by Fukushima and Nixon (7) on a 30 x 5 mm column. The purified pteridines were determined by HPLC.
HP LC-procedure
The chromatographic elution was performed with a 1.7 mmolll aqueous phosphoric acid buffer pH 2.75, containing 7% methanol and 1 % acetonitrile which was filtered and degassed before use. The total analysis time was 20 min. The recovery ofpteridines added to urine before work-up was 95%. The values of pteridines were reproducible to within 5% in double or triple HPLC determinations . Urinary creatinine was determined using a creatinine kit from Sigma (8) .
Chemicals
All pteridines used as standards were from Dr. B. Schircks (Jona, Switzerland).
Statistical analysis
Results from the different groups of animals were analyzed by an one-way analysis of variance. When a significant (p < 0.1) effect was detected, means from the groups of tumour animals were compared with those from controls using Student's t-test. Differences between means were considered significant when p < 0.05 . 
Results
Dogs
Dogs with mammary tumours:
In this group of 21 dogs all except 2 cases were mixed tumours of low malignancy. Biopterin, pterin and isoxanthopterin showed significant increases (Tab. 1). 
Cats with feline infectious peritonitis ( FlPJ:
In this group of 8 male and 6 female cats, an infection with FIP was diagnosed based on the typical exudate and on the high titre of antibody (serum neutralisation test). A significant increase was found in all 5 pteridines investigated (Tab. 4). The peak values of the pteridines were higher than in cats infected with FeLV 
Discussion
Clinical healthy dogs and cats
In control dogs no different pteridine values were found due to various size and breed. Neopterin and biopterin excretions measured in urine agree well with the data found in another investigation (9) . Changes in the pteridine excretion due to age, as measured in human (10) could not be seen. The differences between male and female dogs were so slight that all values could be summarized as a control group. In human, males have a higher neopterin excretion than females. Pteridine values of cats are not yet described in the literature. Age, sex, size and breed did not show differences in the pteridine levels. A comparison of the urinary pteridine patterns of healthy dogs and cats shows a species specifity (Fig.  1) . The quantitative differences could result in different enzyme activities or other factors, like amount of substrate or feed back mechanisms. Species specific differences are implied in investigations of some species (9, 11) . In comparison to human the value of neopterin loses its evidence. Therefore the often used ratio neopterin/biopterin in human does not make sense. In contrary to cats, 6-hydroxymethylpterin was hardly detectable in dogs. Whereas in dogs biopterin presents the main part of pteridines (about 70%), cats contain about 53% catabolic isoxanthopterin in the pteridine pattern.
Pteridines in dogs with various neoplasias
The conclusion that the urinary pteridine levels in human are altered in neoplasias, is transferable to dogs. Rokos (12) and Stea (2) showed that the excretion of different pteridines increases or decreases in human. Dogs with certain neoplasias demonstrate an urinary increase in most of the pteridines measured, dependent on the kind of tumour. The species specific pattern remains preserved however.
As mentioned above, neopterin in dogs a lone has no evidence. Only in 3 tumours the excretion of neopterin was increased significantly (perianal glands, benign dermatomas and adenocarcinomas/carcinomas). But measuring the other pteridines, each of the tumour groups produced a specific variation in the pteridine pattern and can be distinguished from the other groups by means of this pattern.
The reason for the increased excretion of some pteridines in tumour patients is still poorly understood. Different theories are connected with 2 different influences, the nucleotide metabolism and the cellular immunosystem .
Interactions between pteridines and nucleotide metabolism should be considered, since concentrations of GTP. the precursor of pteridines, are correlated in transplanted tumours and cell cultures with tumour growth and malignancy (13). High concentrations of pteridines may therefore be a consequence of high GTP levels, whereby the proliferation rates of the tumours result in different high GTP values. This would explain the quantitative differences in the total amount of pteridines in various tumours. Another reason for the increased pteridines could be the elevated activity of cytosinetriphosphate-synthetase reported in quick-growing tumours (14) . Jackson and Weber (15) documented increased activities of adenosine monphosphat (AMP) deaminase and inosine monophosphat (IMP) dehydrogenase in connection with malignancy and proliferation rate, leading to an increasing formation capacity of IMP and thus to an elevated employment in the de novo biosynthesis of GTP.
Parallel to this theory the interpretation developed more and more that the excretion of pteridines is involved in the proliferation and differenciation of Tlymphocytes. In vitro experiments showed that macrophages produce neopterin by mediation of interferon-,), (16) . However, the interactions between activated T-Iymphocytes and the monocyte/macrophage system are not confined to neopterin only, but lead to an increased biosynthesis of dihydroneopterin triphosphate (17) . Therefore, the result is an elevated excretion of biopterin and its catabolic pteridines, parallel to the maxima of neopterin.
But where do the different alterations in the amount of excreted pteridines in various tumours come from? The dignity of the tumours does not seem to have a decisive role, in contrary to the human medicine, where no elevated pteridines were determined in benign tumours (18) . The various developmental speed of the tumours may be responsible for the alterations. A long existing tumour, such as benign neoplasias, shows high pteridine values in the urine.
Normal biopterin values together with high levels of the other pteridines may indicate a deficiency in biopterin biosynthesis as described in atypic phenylketonuria in man (19, 20) . A deficiency in dihydropterin reductase in contrast leads to an accumulation of biopterin (19) . Increased values of isoxanthopterin, the terminal product of the pteridine catabolism (21), reflect an elevated pteridine synthesis with increased catabolism or increased xanthine oxidase activity, respectively.
Pteridines in viral infections
Cats and dogs suffering from viral diseases show a similar pteridine pattern as tumour bearing animals. In comparison to the neoplasias, the viral infections resulted in distinctly elevated concentrations of all pteridines. This suggests that in viral diseases the response of the immunosystem is more intensive than in tumours. The species specific distribution of the pteridines remains constant. The proportions in dogs with identified parvovirosis and in parvovirosis suspicious animals are characteristic. The same clinical symptoms of the dogs with suspected parvovirosis do not result in increased pteridine excretions, in contrary to the virus carriers. The folic acid metabolism possibly is responsible for the increase of catabolic pterin in these virusfree dogs. Tetrahydrofolic acid is transformed to pterin in 50% with acidic oxidation. These data suggest that the elevated pterin originates from tetrahydrofolic acid or its derivates (7) .
In FeLV-positive cats, which died within a week, the essentially increased pteridine values give evidence for the advanced process of the disease. As in viral infections in human (12) , no differences are found in the pteridine pattern of FIP and FeLY.
Altogether, a single reason for the altered urinary pteridine concentrations in neoplasias and viral infections does not seem to be probable. The results presented suggest that pteridines in general are connected with processes in the cellular immunosystem.
The specific alterations in pteridine patterns lead to the supposition of some differences in the activation of T-Iymphocytes and so-called "local influences". A varying pteridine metabolism could also be responsible for the examined values. Elevated values of pteridines in urine present a real additional aid for the suspicion of neoplasias or viral infections.
